CIPDB › China Industry › Chemicals › Pharmaceutical Chemicals
China, Chinese Antidiabetic Melanotan 2 99% GLP-1 API Powder1 Industrial Products Supplier Manufacturer Details, price list catalog:
China Products Details Supplier Manufacturer price list catalog
Pharmaceutical ChemicalsMelanotanWeight Loss
QINGDAO ASPIRIT CHEMICAL CO., LTD.
Preview:
Product Description Product Name:peptide-1 (GLP-1)Molecular Formula:C187H291N45O59Formula Weight:4113.57754Appearance:Solid powderPurity:>98%Storage:Dry, dark, and at 0 - 4 C for the short term (days to weeks) or -20 C for the long term (months to years).Solubility:Soluble in DMSShipping Condition:Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.WHAT IS peptide-1 (GLP-1) AND HOW DOES IT WORK?Peptide-1 (GLP-1) is a prescription medication used to treat Type 2 Diabetes Mellitus and for Weight ManagementWHAT ARE DOSAGES OF peptide-1 (GLP-1)?Adult dosageInjection, prefilled, single-dose pen 2mg/1.5mL (1.34mg/mL); delivers doses of 0.25mg, 0.5mg, or 1mg per injection4mg/3mL (1.34mg/mL); delivers 1 mg per injectionInjection, prefilled, single-dose pen 0.25mg/0.5mL0.5mg/0.5mL1mg/0.5mL1.7mg/0.75mL2.4mg/0.75mLOral tablet 3mg7mg14mgType 2 Diabetes MellitusAdult dosageSC0.25 mg SC once per week for 4 weeks initially; then increase to 0.5 mg per weekIf glycemic control is not achieved after at least 4 weeks on a 0.5-mg dose, can increase to 1 mg once weeklyNote: the initial 0.25-mg dose is intended for treatment initiation and is not effective for glycemic controlOralInitial: 3 mg orally once daily for 30 days; then the 3-mg dose is intended for treatment initiation and is not effective for glycemic controlAfter 30 days on 3 mg/day: increase to 7 mg orally once dailyAfter 30 days on 7 mg/day: may increase the dose to 14 mg orally once daily if additional glycemic control neededNote: Taking two 7-mg tablets to achieve a 14 mg dose is not recommendedSwitching between peptide-1 (GLP-1) and Ryhelsus (orally)Taking 14 mg/day orally: Transition to 0.5 mg SC once weekly on the day after the last oral doseTaking 0.5 mg/week SC: Transition to 7 mg or 14 mg orally starting up to 7 days after last SC injectionThere is no equivalent oral dose for the 1-mg SC doseWeight ManagementAdult dosageInitiate with a low dose and gradually escalate to a maintenance dose of 2.4 mg/week SC to minimize GI adverse reactionsIf unable to tolerate maintenance dose of 2.4 mg once-weekly, may temporarily decrease to 1.7 mg once weekly, for a maximum of 4 weeks; after 4 weeks, increase back to maintenance 2.4 mg once-weekly; discontinue if not tolerated after the second attempt Weeks 1-4: 0.25 mgWeeks 5-8: 0.5 mgWeeks 9-12: 1 mgWeeks 13-16: 1.7 mgWeek 17 onward: 2.4 mg (maintenance)
Purchasing Agent
Note: Send your message to supplier or manufacturer.
Welcome to our Professional and comprehensive procurement services...